Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AME Study of [14C]Mizagliflozin in Healthy Male Subjects
NCT02434835Phase 1Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mizagliflozin in chronic constipation, sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoints: Area under the plasma concentration-time curve at 240 hours, Maximum observed plasma concentration at 240 hours and 2 more. Status: completed.
02
Drugs
mizagliflozin
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT02434835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434835.